Dankó, T.; Petővári, G.; Sztankovics, D.; Moldvai, D.; Raffay, R.; Lőrincz, P.; Visnovitz, T.; Zsiros, V.; Barna, G.; Márk, Á.;
et al. Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells. Int. J. Mol. Sci. 2021, 22, 8019.
https://doi.org/10.3390/ijms22158019
AMA Style
Dankó T, Petővári G, Sztankovics D, Moldvai D, Raffay R, Lőrincz P, Visnovitz T, Zsiros V, Barna G, Márk Á,
et al. Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells. International Journal of Molecular Sciences. 2021; 22(15):8019.
https://doi.org/10.3390/ijms22158019
Chicago/Turabian Style
Dankó, Titanilla, Gábor Petővári, Dániel Sztankovics, Dorottya Moldvai, Regina Raffay, Péter Lőrincz, Tamás Visnovitz, Viktória Zsiros, Gábor Barna, Ágnes Márk,
and et al. 2021. "Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells" International Journal of Molecular Sciences 22, no. 15: 8019.
https://doi.org/10.3390/ijms22158019
APA Style
Dankó, T., Petővári, G., Sztankovics, D., Moldvai, D., Raffay, R., Lőrincz, P., Visnovitz, T., Zsiros, V., Barna, G., Márk, Á., Krencz, I., & Sebestyén, A.
(2021). Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells. International Journal of Molecular Sciences, 22(15), 8019.
https://doi.org/10.3390/ijms22158019